PEQINI, KALIROI
PEQINI, KALIROI
Dipartimento di Scienze Farmaceutiche
Breaking down and building up alpha‐synuclein: An insight on its N‐terminal domain
2023 K. Peqini, S. Attanasio, L. Feni, G. Cappelletti, S. Pellegrino
DEVELOPMENT OF MOLECULAR PROBES ACTING ON aSYN/TUBULIN AND TAU/TUBULIN INTERACTION
2023 K. Peqini
L- to D-Amino Acid Substitution in the Immunodominant LCMV-Derived Epitope gp33 Highlights the Sensitivity of the TCR Recognition Mechanism for the MHC/Peptide Structure and Dynamics
2022 F. Ballabio, L. Broggini, C. Paissoni, X. Han, K. Peqini, B.M. Sala, R. Sun, T. Sandalova, A. Barbiroli, A. Achour, S. Pellegrino, S. Ricagno, C. Camilloni
Multi-eGO: An in silico lens to look into protein aggregation kinetics at atomic resolution
2022 E. Scalone, L. Broggini, C. Visentin, D. Erba, F. Bačić Toplek, K. Peqini, S. Pellegrino, S. Ricagno, C. Paissoni, C. Camilloni
Multi-{eGO}: an in-silico lens to look into protein aggregation kinetics at atomic resolution
2022 E. Scalone, L. Broggini, C. Visentin, D. Erba, F. Ba( (c))i('(c)) Toplek, K. Peqini, S. Pellegrino, S. Ricagno, C. Paissoni, C. Camilloni
Rational Design of a Peptidomimetic Inhibitor of Gelsolin Amyloid Aggregation
2022 M. Bollati, K. Peqini, L. Barone, C. Natale, M. Beeg, M. Gobbi, L. Diomede, M. Trucchi, M. de Rosa, S. Pellegrino
Tuning antiviral CD8 T-cell response via proline-altered peptide ligand vaccination
2020 A.D. Duru, R. Sun, E.B. Allerbring, J. Chadderton, N. Kadri, X. Han, K. Peqini, H. Uchtenhagen, C. Madhurantakam, S. Pellegrino, T. Sandalova, P. Nygren, S.J. Turner, A. Achour
α-Synuclein: An All-Inclusive Trip Around its Structure, Influencing Factors and Applied Techniques
2021 N. Bisi, L. Feni, K. Peqini, H. Pérez-Peña, S. Ongeri, S. Pieraccini, S. Pellegrino